Syndax Pharmaceuticals (SNDX) Work In Process (2024 - 2026)

Syndax Pharmaceuticals' Work In Process history runs 3 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• In Q1 2026, Work In Process rose 401.57% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $2.9 million (up 401.57% YoY), while the FY2025 annual figure was $2.1 million, up 540.0% from the prior year.
• Work In Process was $2.9 million for Q1 2026 at Syndax Pharmaceuticals, up from $2.1 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $2.9 million in Q1 2026 to a low of $330000.0 in Q4 2024.
• Historically, Work In Process has averaged $1.4 million across 3 years, with a median of $1.3 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Work In Process soared 540.0% in 2025, then soared 401.57% in 2026.
• A 3-year view of Work In Process shows it stood at $330000.0 in 2024, then jumped by 540.0% to $2.1 million in 2025, then soared by 35.84% to $2.9 million in 2026.
• The last three Work In Process figures came in at $2.9 million (Q1 2026), $2.1 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.